<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The aim of this study was to investigate the association between plasma COOH-terminal proendothelin-1 (CT-proET-1) and fatal cardiovascular events, <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality, and new-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:mp ids='MP_0002871'>albuminuria</z:mp> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: A total of 1,225 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> participated in this prospective observational study of two combined cohorts </plain></SENT>
<SENT sid="2" pm="."><plain>Three clinical end points were studied: fatal cardiovascular events, <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality, and new-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:mp ids='MP_0002871'>albuminuria</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>After a median follow-up of 3 or 10 years, Cox proportional hazard modeling was used to investigate the association between CT-proET-1 and the end points </plain></SENT>
<SENT sid="4" pm="."><plain>Harrell C statistic, the Groennesby and Borgan test, the integrated discrimination improvement (IDI), and the net reclassification improvement (NRI) were used to evaluate whether CT-proET-1 is of additional value compared with classic cardiovascular and renal risk factors </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: During follow-up, 364 (30%) patients died, 150 (42%) of whom died of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>; 182 (26.7%) of 688 patients with normoalbuminuria at baseline developed <z:mp ids='MP_0002871'>albuminuria</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>CT-proET-1 was associated with fatal cardiovascular events, <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality, and new-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:mp ids='MP_0002871'>albuminuria</z:mp> with hazard ratios of 1.59 (95% CI 1.15-2.20), 1.41 (95% CI 1.14-1.74), and 1.48 (95% CI 1.10-2.01), respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Addition of CT-proET-1 to a model containing traditional risk factors leads only to improved prediction of fatal cardiovascular events </plain></SENT>
<SENT sid="8" pm="."><plain>The IDI appeared significant for fatal cardiovascular events (0.82 [0.1-1.54]) and <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality (0.4 [0.05-0.92]), but not for new-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:mp ids='MP_0002871'>albuminuria</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: CT-proET-1 has additional value for the prediction of fatal cardiovascular events and new-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:mp ids='MP_0002871'>albuminuria</z:mp> in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, compared with conventional risk factors, but not for <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality </plain></SENT>
</text></document>